DENTSPLY SIRONA Inc. $XRAY Stock Sold by VIRGINIA RETIREMENT SYSTEMS ET Al

VIRGINIA RETIREMENT SYSTEMS ET Al lessened its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 36.4% in the third quarter, HoldingsChannel.com reports. The firm owned 143,600 shares of the medical instruments supplier’s stock after selling 82,100 shares during the quarter. VIRGINIA RETIREMENT SYSTEMS ET Al’s holdings in DENTSPLY SIRONA were worth $1,272,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in XRAY. Oregon Public Employees Retirement Fund boosted its holdings in DENTSPLY SIRONA by 3.3% during the first quarter. Oregon Public Employees Retirement Fund now owns 40,944 shares of the medical instruments supplier’s stock worth $475,000 after buying an additional 1,300 shares in the last quarter. Allworth Financial LP grew its position in DENTSPLY SIRONA by 163.8% during the second quarter. Allworth Financial LP now owns 4,815 shares of the medical instruments supplier’s stock worth $51,000 after buying an additional 2,990 shares during the period. Nykredit A S purchased a new position in DENTSPLY SIRONA in the second quarter valued at about $38,000. IFP Advisors Inc increased its holdings in DENTSPLY SIRONA by 244.4% in the third quarter. IFP Advisors Inc now owns 5,566 shares of the medical instruments supplier’s stock valued at $49,000 after buying an additional 3,950 shares in the last quarter. Finally, Pictet Asset Management Holding SA lifted its position in shares of DENTSPLY SIRONA by 13.5% during the 1st quarter. Pictet Asset Management Holding SA now owns 37,368 shares of the medical instruments supplier’s stock valued at $433,000 after acquiring an additional 4,437 shares during the period. Institutional investors and hedge funds own 95.70% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently commented on the company. Barrington Research decreased their price target on DENTSPLY SIRONA from $15.00 to $13.00 and set an “outperform” rating on the stock in a research note on Monday, October 26th. Leerink Partners dropped their price objective on DENTSPLY SIRONA from $14.00 to $10.00 and set a “market perform” rating for the company in a research note on Wednesday, October 14th. Mizuho reduced their price objective on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a report on Thursday, October 22nd. Barclays boosted their target price on DENTSPLY SIRONA from $9.00 to $11.00 and gave the stock an “underweight” rating in a research report on Monday, August 24th. Finally, Piper Sandler lowered their target price on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a report on Friday, October 9th. Three equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $12.62.

DENTSPLY SIRONA Trading Up 9.5%

Shares of XRAY opened at $10.65 on Thursday. The company has a debt-to-equity ratio of 1.48, a current ratio of 1.63 and a quick ratio of 1.07. The firm has a 50 day simple moving average of $9.65 and a 200-day simple moving average of $11.30. DENTSPLY SIRONA Inc. has a 1-year low of $8.32 and a 1-year high of $14.76. The stock has a market cap of $2.12 billion, a price-to-earnings ratio of 6.80, a price-to-earnings-growth ratio of 1.25 and a beta of 0.87.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.35 by $0.17. DENTSPLY SIRONA had a positive return on equity of 20.84% and a negative net margin of 14.99%. The firm had revenue of $898.00 million during the quarter, compared to the consensus estimate of $889.93 million. During the same period in the previous year, the firm posted $0.52 EPS. The company’s quarterly revenue was down 4.1% compared to the same quarter last year. Equities analysts forecast that DENTSPLY SIRONA Inc. will post 1.39 EPS for the current fiscal year.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental specialists, dental laboratories and other oral health professionals with solutions used in preventive, restorative, prosthetic, endodontic and implant dentistry.

Its portfolio includes dental equipment, imaging and treatment systems, CAD/CAM technology, consumable dental materials, orthodontic products, endodontic instruments and solutions, dental implants, prosthetic components and laboratory products.